Advertisement
Letter|Articles in Press, 155561

Letter to the Editor: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences

  • Kiranmayee Muralidhar
    Correspondence
    Corresponding author at: Public Health Research Institute of India, 89/B, Ambika, 2nd Main, 2nd Cross, Yadavagiri, Mysore, Karnataka 570020, India.
    Affiliations
    Public Health Research Institute of India, Mysore, Karnataka, India

    JSS Academy of Higher Education and Research, Mysore, Karnataka, India
    Search for articles by this author
  • Purnima Madhivanan
    Affiliations
    Public Health Research Institute of India, Mysore, Karnataka, India

    Mel & Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
    Search for articles by this author
Published:April 16, 2023DOI:https://doi.org/10.1016/j.metabol.2023.155561
Letter to the Editor: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Previous ArticleRegulation of pericyte metabolic reprogramming restricts the AKI to CKD transition
Next ArticleResponse to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
      We have read the review titled “Epidemiology of sarcopenia: Prevalence, risk factors, and consequences” by Yuan and Larsson [
      • Yuan S.
      • Larsson S.C.
      Epidemiology of sarcopenia: prevalence, risk factors, and consequences [published online ahead of print, 2023 Mar 11].
      Metabolism. 2023; 155533https://doi.org/10.1016/j.metabol.2023.155533
      ] recently published in Metabolism. We appreciate the authors for selecting this highly important topic which is growing in relevance as most countries face aging populations. However, there is some uncertainty on the type of review conducted, and methodological issues that question the validity of the findings.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Yuan S.
        • Larsson S.C.
        Epidemiology of sarcopenia: prevalence, risk factors, and consequences [published online ahead of print, 2023 Mar 11].
        Metabolism. 2023; 155533https://doi.org/10.1016/j.metabol.2023.155533
        View in Article
        • Page M.J.
        • McKenzie J.E.
        • Bossuyt P.M.
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        Syst Rev. 2021; 10 (Published 2021 Mar 29): 89https://doi.org/10.1186/s13643-021-01626-4
        View in Article
        • Pieper D.
        • Rombey T.
        Where to prospectively register a systematic review.
        Syst Rev. 2022; 11: 8
        View in Article
        • Rothstein H.R.
        • Sutton A.J.
        • Borenstein M.
        Publication bias in meta-analysis. Publication bias in meta-analysis: prevention, assessment and adjustments. 2005: 1-7
        View in Article
        • Trikalinos T.A.
        • Ioannidis J.P.
        Assessing the evolution of effect sizes over time. Publication bias in meta-analysis: prevention, assessment and adjustments. 2005: 241-259
        View in Article

      Article info

      Publication history

      Published online: April 16, 2023
      Accepted: April 12, 2023
      Received: April 6, 2023

      Publication stage

      In Press Journal Pre-Proof

      Identification

      DOI: https://doi.org/10.1016/j.metabol.2023.155561

      Copyright

      © 2023 Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX